“The candidate is reportedly generating the kind of immune response researchers were hoping to see, although efficacy has to be properly evaluated in the final phase of trials currently undertaken in Brazil.
The jab, which will be mass-produced by AstraZeneca PLC (LON:AZN), is stimulating both antibodies and T-cells, which kill the virus. It is one of the few vaccine projects producing this twin effect.“
FTSE 100 jumps 125 points on positive Oxford COVID-19 vaccine news; Wall Street to open in the green
Exciting News Expected on Oxford Vaccine
Discussion in 'News & Current Events' started by KenH, Jul 15, 2020.
-
I don't anticpate taking the vaccine, but I might invest in it to make some quick bucks. I would not want to invest in it if aborted fetal tissue is used in its' production.
-
Scott Downey Well-Known Member
Which COVID-19 Vaccines Are Being Developed with Aborted Babies?
Several COVID-19 vaccine frontrunners, including those being developed by Moderna, Oxford University/AstraZeneca, CanSino Biologics/Beijing Institute of Biotechnology, and Inovio Pharmaceuticals, are using a human fetal kidney cell line called HEK-293 to develop their trial vaccines. HEK-293 was originally derived from kidney tissue taken from a baby girl who was aborted in the Netherlands in 1972 and later developed into a cell line in a lab in 1973.
Additionally, Janssen, the pharmaceutical division of consumer product giant Johnson & Johnson, is using the human fetal cell line PER.C6 to develop its vaccine. The PER.C6 fetal cell line was derived from retinal tissue taken from an 18-week-old baby boy who was aborted in the Netherlands in 1985 and later converted into a fetal cell line in 1995.
As to what is actually in any vaccines, you just don't know what they have put into them for certain.